<?xml version="1.0" encoding="UTF-8"?>
<p>In China, stem cells are currently being studied as a treatment for nCOVID-19. Tocilizumab (a mAb) is an immunosuppressive agent and is used to treat rheumatoid arthritis (Kaneko, 
 <xref rid="B97" ref-type="bibr">2013</xref>). This agent was designed to suppress the IL-6 binding with its receptors to alleviate cytokine storm syndrome. Tocilizumab is now being studied as a potential nCOVID-19 treatment (Jean et al., 
 <xref rid="B93" ref-type="bibr">2020b</xref>; Slater, 
 <xref rid="B170" ref-type="bibr">2020</xref>).
</p>
